Siri Atma W. Greeley to Genetic Testing
This is a "connection" page, showing publications Siri Atma W. Greeley has written about Genetic Testing.
Connection Strength
2.770
-
Monogenic diabetes: the impact of making the right diagnosis. Curr Opin Pediatr. 2018 08; 30(4):558-567.
Score: 0.486
-
Congenital Diabetes: Comprehensive Genetic Testing Allows for Improved Diagnosis and Treatment of Diabetes and Other Associated Features. Curr Diab Rep. 2018 06 13; 18(7):46.
Score: 0.481
-
Response letter to the editor. J Clin Endocrinol Metab. 2015 Jan; 100(1):L14.
Score: 0.379
-
Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons. J Clin Endocrinol Metab. 2014 Dec; 99(12):E2709-14.
Score: 0.377
-
Genomic sequencing in newborn screening programs. JAMA. 2012 May 23; 307(20):2146-7; author reply 2147.
Score: 0.316
-
The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011 Mar; 34(3):622-7.
Score: 0.289
-
Novel compound heterozygous LRBA deletions in a 6-month-old with neonatal diabetes. Diabetes Res Clin Pract. 2021 May; 175:108798.
Score: 0.146
-
Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA. J Clin Endocrinol Metab. 2018 01 01; 103(1):35-45.
Score: 0.117
-
Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach. Mol Genet Metab. 2014 Dec; 113(4):315-320.
Score: 0.093
-
Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care. 2014; 37(1):202-9.
Score: 0.087